Orthocell

Orthocell Dividend Growth

Year-over-Year Dividend Growth of Orthocell (OCC.AX) as of Nov 17, 2026.

Dividend Growth

-

Last updated:

Year-over-Year Dividend Growth of Orthocell is 2026 - . Year-over-Year Dividend Growth of Orthocell was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Orthocell Stock analysis

What does Orthocell do? Orthocell Ltd develops and commercializes cell therapies and related technologies focused on regenerating mobility for patients with bone and soft tissue injuries. The company's products include CelGro, a collagen medical device using SMRT manufacturing for tissue reconstruction in dental and orthopedic applications, Striate+ for dental GBR, Remplir for peripheral nerve reconstruction, and SmrtGraft for tendon repair. Autologous cell therapy, particularly its tendon cell therapy in development in the United States, targets chronic tendon injuries through advanced injectable cellular therapy for cartilage and tendon regeneration. Orthocell's primary customers are healthcare providers and medical institutions requiring advanced tissue repair solutions. The company generates revenue through the sale of its medical devices and cell therapy products, with CelGro and related SMRT manufacturing processes forming a core part of its commercial portfolio. Its autologous tendon therapy development in the U.S. represents a key growth segment targeting chronic tendon injury treatments. The company's product portfolio is structured around regenerative medicine applications, with CelGro serving dental and orthopedic markets, Striate+ specifically for dental GBR, Remplir addressing nerve reconstruction needs, and SmrtGraft focused on tendon repair. Orthocell's commercial strategy emphasizes direct sales of these products to healthcare professionals and institutions seeking innovative solutions for tissue repair and regeneration. Orthocell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orthocell stock

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Orthocell since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Orthocell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Orthocell

All Key Metrics — Orthocell